Development of a microcolumn one-site immunometric assay for a protein biomarker: Analysis of alpha1-acid glycoprotein

Chenhua Zhang, Shae Lott, William Clarke, David S. Hage

Research output: Contribution to journalArticle

Abstract

A one-site immunometric assay based on affinity microcolumns was developed for the analysis of alpha1-acid glycoprotein (AGP) as a model protein biomarker. In this assay, a sample containing AGP was incubated with an excess amount of a labeled binding agent, such as fluorescein-labeled anti-AGP antibodies or Fab fragments. The excess binding agent was removed by passing this mixture through a microcolumn that contained an immobilized form of AGP, while the signal was measured for the binding agent-AGP complex in the non-retained fraction. Theoretical and practical factors were both considered in selecting the concentration of labeled binding agent, the incubation time of this agent with the sample, and the application conditions for this mixture onto the microcolumn. The effects of using various labeling methods and intact antibodies vs Fab fragments were also considered. The final assay was performed with fluorescein-labeled anti-AGP antibodies and a 2.1 mm i.d. × 1.0 cm AGP microcolumn operated at 0.30 mL min−1. This method required only 1 µL of serum or plasma, had a detection limit of 0.63 nM AGP, and gave a potential throughput of 2 min per sample. This assay was used to measure AGP in normal serum and plasma from patients with systemic lupus erythematosus, giving good agreement with the literature and a reference method. The same approach and guidelines can be used to create assays for other protein biomarkers by changing the labeled binding agent and immobilized protein within the microcolumn.

Original languageEnglish (US)
Article number460558
JournalJournal of Chromatography A
Volume1610
DOIs
StatePublished - Jan 11 2020

Fingerprint

Biomarkers
Assays
Glycoproteins
Acids
Proteins
Immunoglobulin Fab Fragments
Fluorescein
Immobilized Proteins
Plasmas
Immunoglobulin Fragments
Antibodies
Serum
Systemic Lupus Erythematosus
Labeling
Limit of Detection
Carrier Proteins
Throughput
Guidelines

Keywords

  • Affinity microcolumn
  • Alpha-acid glycoprotein
  • Chromatographic immunoassay
  • One-site immunometric assay
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Organic Chemistry

Cite this

Development of a microcolumn one-site immunometric assay for a protein biomarker : Analysis of alpha1-acid glycoprotein. / Zhang, Chenhua; Lott, Shae; Clarke, William; Hage, David S.

In: Journal of Chromatography A, Vol. 1610, 460558, 11.01.2020.

Research output: Contribution to journalArticle

@article{5e8c085a4d6741189730839fe386f2b9,
title = "Development of a microcolumn one-site immunometric assay for a protein biomarker: Analysis of alpha1-acid glycoprotein",
abstract = "A one-site immunometric assay based on affinity microcolumns was developed for the analysis of alpha1-acid glycoprotein (AGP) as a model protein biomarker. In this assay, a sample containing AGP was incubated with an excess amount of a labeled binding agent, such as fluorescein-labeled anti-AGP antibodies or Fab fragments. The excess binding agent was removed by passing this mixture through a microcolumn that contained an immobilized form of AGP, while the signal was measured for the binding agent-AGP complex in the non-retained fraction. Theoretical and practical factors were both considered in selecting the concentration of labeled binding agent, the incubation time of this agent with the sample, and the application conditions for this mixture onto the microcolumn. The effects of using various labeling methods and intact antibodies vs Fab fragments were also considered. The final assay was performed with fluorescein-labeled anti-AGP antibodies and a 2.1 mm i.d. × 1.0 cm AGP microcolumn operated at 0.30 mL min−1. This method required only 1 µL of serum or plasma, had a detection limit of 0.63 nM AGP, and gave a potential throughput of 2 min per sample. This assay was used to measure AGP in normal serum and plasma from patients with systemic lupus erythematosus, giving good agreement with the literature and a reference method. The same approach and guidelines can be used to create assays for other protein biomarkers by changing the labeled binding agent and immobilized protein within the microcolumn.",
keywords = "Affinity microcolumn, Alpha-acid glycoprotein, Chromatographic immunoassay, One-site immunometric assay, Systemic lupus erythematosus",
author = "Chenhua Zhang and Shae Lott and William Clarke and Hage, {David S.}",
year = "2020",
month = "1",
day = "11",
doi = "10.1016/j.chroma.2019.460558",
language = "English (US)",
volume = "1610",
journal = "Journal of Chromatography A",
issn = "0021-9673",

}

TY - JOUR

T1 - Development of a microcolumn one-site immunometric assay for a protein biomarker

T2 - Analysis of alpha1-acid glycoprotein

AU - Zhang, Chenhua

AU - Lott, Shae

AU - Clarke, William

AU - Hage, David S.

PY - 2020/1/11

Y1 - 2020/1/11

N2 - A one-site immunometric assay based on affinity microcolumns was developed for the analysis of alpha1-acid glycoprotein (AGP) as a model protein biomarker. In this assay, a sample containing AGP was incubated with an excess amount of a labeled binding agent, such as fluorescein-labeled anti-AGP antibodies or Fab fragments. The excess binding agent was removed by passing this mixture through a microcolumn that contained an immobilized form of AGP, while the signal was measured for the binding agent-AGP complex in the non-retained fraction. Theoretical and practical factors were both considered in selecting the concentration of labeled binding agent, the incubation time of this agent with the sample, and the application conditions for this mixture onto the microcolumn. The effects of using various labeling methods and intact antibodies vs Fab fragments were also considered. The final assay was performed with fluorescein-labeled anti-AGP antibodies and a 2.1 mm i.d. × 1.0 cm AGP microcolumn operated at 0.30 mL min−1. This method required only 1 µL of serum or plasma, had a detection limit of 0.63 nM AGP, and gave a potential throughput of 2 min per sample. This assay was used to measure AGP in normal serum and plasma from patients with systemic lupus erythematosus, giving good agreement with the literature and a reference method. The same approach and guidelines can be used to create assays for other protein biomarkers by changing the labeled binding agent and immobilized protein within the microcolumn.

AB - A one-site immunometric assay based on affinity microcolumns was developed for the analysis of alpha1-acid glycoprotein (AGP) as a model protein biomarker. In this assay, a sample containing AGP was incubated with an excess amount of a labeled binding agent, such as fluorescein-labeled anti-AGP antibodies or Fab fragments. The excess binding agent was removed by passing this mixture through a microcolumn that contained an immobilized form of AGP, while the signal was measured for the binding agent-AGP complex in the non-retained fraction. Theoretical and practical factors were both considered in selecting the concentration of labeled binding agent, the incubation time of this agent with the sample, and the application conditions for this mixture onto the microcolumn. The effects of using various labeling methods and intact antibodies vs Fab fragments were also considered. The final assay was performed with fluorescein-labeled anti-AGP antibodies and a 2.1 mm i.d. × 1.0 cm AGP microcolumn operated at 0.30 mL min−1. This method required only 1 µL of serum or plasma, had a detection limit of 0.63 nM AGP, and gave a potential throughput of 2 min per sample. This assay was used to measure AGP in normal serum and plasma from patients with systemic lupus erythematosus, giving good agreement with the literature and a reference method. The same approach and guidelines can be used to create assays for other protein biomarkers by changing the labeled binding agent and immobilized protein within the microcolumn.

KW - Affinity microcolumn

KW - Alpha-acid glycoprotein

KW - Chromatographic immunoassay

KW - One-site immunometric assay

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85072605259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072605259&partnerID=8YFLogxK

U2 - 10.1016/j.chroma.2019.460558

DO - 10.1016/j.chroma.2019.460558

M3 - Article

C2 - 31564560

AN - SCOPUS:85072605259

VL - 1610

JO - Journal of Chromatography A

JF - Journal of Chromatography A

SN - 0021-9673

M1 - 460558

ER -